Skip to main content
. 2010 Oct 6;65(12):2574–2581. doi: 10.1093/jac/dkq366

Table 1.

Strains used in this study: mycobacterial isolates, their resistant derivatives selected after exposure to the indicated disinfectants and revertants obtained by restreaking the resistant strains on medium without disinfectant

Strain Origin
M. massiliense WT 1.0 M. massiliense clinical isolate LTE3550
M. massiliense 1.2 M. massiliense WT 1.0 selected in 9% CTAB
M. abscessus WT 2.0 M. abscessus clinical isolate LTE3514
M. abscessus 2.1 M. abscessus WT 2.0 selected in 9% CTAB
M. abscessus 2.1.3 M. abscessus 2.1 restreaked 3 times
M. abscessus 2.1.6 M. abscessus 2.1 restreaked 6 times
M. abscessus 2.2 M. abscessus WT 2.0 selected in 9% DBLAB
M. abscessus 2.2.3 M. abscessus 2.2 restreaked 3 times
M. abscessus 2.2.6 M. abscessus 2.2 restreaked 6 times
M. abscessus 2.3 M. abscessus WT 2.0 selected in glutaraldehyde 2% for 5 min
M. abscessus 2.3.3 M. abscessus 2.3 restreaked 3 times
M. abscessus 2.3.6 M. abscessus 2.3 restreaked 6 times
M. fortuitum WT 1.0 M. fortuitum clinical isolate LTE1428
M. fortuitum 1.2 M. fortuitum WT 1.0 selected in 9% DBLAB
M. chelonae WT 2.0 M. chelonae clinical isolate LTE2714
M. chelonae 2.1 M. chelonae WT 2.0 selected in 9% CTAB
M. chelonae 2.2 M. chelonae WT 2.0 selected in 9% DBLAB
M. fortuitum WT 3.0 M. fortuitum environmental isolate LTE2297
M. fortuitum 3.2 M. fortuitum WT 3.0 selected in 9% DBLAB
M. terrae ATCC 15755
M. smegmatis mc2155 laboratory strain (Laboratorio de Genética Molecular, IVIC)
M. bovis BCG laboratory strain (Laboratorio de Genética Molecular, IVIC)